Dry Needling and Kinesio Taping as Adjuncts to Strength Training on Pain, Functional Mobility, and Quality of Life in Patients With Knee Osteoarthritis
Comparative Effects of Dry Needling and Kinesio Taping as Adjuncts to Strength Training on Pain, Functional Mobility, and Quality of Life in Patients With Knee Osteoarthritis: A Three-Arm Randomized Controlled Trial
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
Background: Knee osteoarthritis (OA) is a progressive degenerative joint condition characterized by pain, myofascial trigger points, muscular weakness, and impaired functional mobility, ultimately affecting quality of life. Strength training is widely recommended as a first-line conservative treatment; however, residual pain and myofascial dysfunction may limit optimal recovery. Dry needling has been shown to deactivate trigger points and reduce local muscle hypertonicity, while Kinesio taping is proposed to modulate pain and support proprioception and muscle function through cutaneous and fascial mechanisms. Comparative evidence on the added benefit of these two adjunct techniques alongside strength training in knee OA remains scarce.
Objective: To compare the effects of dry needling and Kinesio taping, each combined with strength training, on pain, functional mobility, and quality of life in patients with knee OA.
Methodology: A three-arm parallel-group randomized controlled trial was conducted on 50 participants diagnosed with knee OA (Kellgren-Lawrence grade II-III), randomly allocated into three groups using a computer-generated random sequence with allocation concealment. Group A received dry needling combined with strength training, Group B received Kinesio taping combined with strength training, and Group C received strength training alone as the control group. Interventions were administered three times per week for 6 weeks. Outcome measures included the Numeric Pain Rating Scale (NPRS) for pain, the Timed Up and Go (TUG) test for functional mobility, and the WHOQOL-BREF for quality of life, assessed at baseline and post-intervention (6 weeks). Data were analyzed using repeated-measures ANOVA and post-hoc comparisons, with significance set at p<0.05.
Studietype
Studietype
Registrering (Faktiske)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Sindh
-
Karachi, Sindh, Pakistan
- FMRL
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria: Patient with knee osteoarthritis, Age between 45-65 years, VAS 7 or above.
-
Exclusion Criteria: Known allergic conditions, refused to give written consent to participate in the study not fallen in inclusion criteria.
-
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Dry Needling Combined with Strength Training
Dry Needling Combined with Strength Training: Interventions were administered three times per week for 6 weeks
|
Dry Needling Combined with Strength Training were administered three times per week for 6 weeks
|
|
Eksperimentell: Kinesio Taping Combined with Strength Training
Kinesio Taping Combined with Strength Training: Interventions were administered three times per week for 6 weeks
|
Kinesio Taping Combined with Strength Training were administered three times per week for 6 weeks
|
|
Eksperimentell: Strength Training
Strength Training: Interventions were administered three times per week for 6 weeks
|
Strength Training were administered three times per week for 6 weeks
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Numeric Pain Rating Scale (NPRS)
Tidsramme: 6 weeks
|
The value were taken at base line and after 6 weeks of intervention
|
6 weeks
|
|
Timed Up and Go (TUG)
Tidsramme: 6 weeks
|
The value were taken at base line and after 6 weeks of intervention
|
6 weeks
|
|
WHOQOL-BREF
Tidsramme: 6 weeks
|
The value were taken at base line and after 6 weeks of intervention
|
6 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Studieleder: Malika Hassan, fmr.labs@medicalresearchforum.net
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Faktiske)
Primær fullføring
Studiet fullført (Faktiske)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Muskel- og skjelettsykdommer
- Leddgikt
- Leddsykdommer
- Revmatiske sykdommer
- Artrose
- Artrose, kne
- Motorisk aktivitet
- Bevegelse
- Muskel- og skjelettfysiologiske fenomener
- Muskel- og skjelett og nevrale fysiologiske fenomener
- Terapeutikk
- Fysioterapi -modaliteter
- Pasientbehandling
- Treningsterapi
- Rehabilitering
- Ettervern
- Kontinuitet i pasientbehandling
- Fysisk kondisjonering, menneskelig
- Øvelse
- Motstandstrening
Andre studie-ID-numre
Andre studie-ID-numre
- FMRL_04_26
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .